{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T18:34:19Z","timestamp":1781030059765,"version":"3.54.1"},"reference-count":58,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>In November 2018, the UK\u2019s Home Office established a legal route for eligible patients to be prescribed cannabis-based products for medicinal use in humans (CBPMs) as unlicensed medicines. These include liquid cannabis extracts for oral administration (\u201coils\u201d) and dried flowers for inhalation (\u201cflos\u201d). Smoking of CBPMs is expressly prohibited. To date, THC-predominant cannabis flowers remain the most prescribed CBPMs in project Twenty21 (T21), the first multi-center, prospective, observational UK cannabis patient registry. This observational, prospective data review analyzes patient-reported outcome measures (PROMS) collected by T21 associated with the inhalation of KHIRON 20\/1, the most prescribed CBPM in the project. PROMS collected at baseline and at subsequent 3-month follow-up included health-related quality of life (HRQoL), general mood, and sleep. Condition-specific measures of illness severity were performed with the Brief Pain Inventory Short Form (BPI-SF) and the Generalized Anxiety Disorder 7-Item Scale (GAD-7). Participants (N = 344) were mostly males (77.6%, average age = 38.3) diagnosed mainly with chronic pain (50.9%) and anxiety-related disorders (25.3%). Inhalation of KHIRON 20\/1 was associated with a marked increase in self-reported HRQoL, general mood, and sleep (N = 344; p &lt; 0.001). Condition-specific assessments showed significant improvements in pain severity (T = 6.67; p &lt; 0.001) and interference (T = 7.19; p &lt; 0.001) in patients using KHIRON 20\/1 for chronic pain (N = 174). Similar results were found for patients diagnosed with anxiety-related disorders (N = 107; T = 12.9; p &lt; 0.001). Our results indicate that controlled inhalation of pharmaceutical grade, THC-predominant cannabis flos is associated with a significant improvement in patient-reported pain scores, mood, anxiety, sleep disturbances and overall HRQoL in a treatment-resistant clinical population.<\/jats:p>","DOI":"10.3390\/biomedicines10102576","type":"journal-article","created":{"date-parts":[[2022,10,16]],"date-time":"2022-10-16T21:10:10Z","timestamp":1665954610000},"page":"2576","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["\u201cFlower Power\u201d: Controlled Inhalation of THC-Predominant Cannabis Flos Improves Health-Related Quality of Life and Symptoms of Chronic Pain and Anxiety in Eligible UK Patients"],"prefix":"10.3390","volume":"10","author":[{"given":"Guillermo","family":"Moreno-Sanz","sequence":"first","affiliation":[{"name":"Khiron Life Sciences Spain, 28001 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9969-4887","authenticated-orcid":false,"given":"Alvaro","family":"Madiedo","sequence":"additional","affiliation":[{"name":"Khiron Life Sciences, Bogot\u00e1 110221, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lynskey","sequence":"additional","affiliation":[{"name":"Drug Sciences, London SW7 2BX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R. D.","family":"Brown","sequence":"additional","affiliation":[{"name":"Zerenia Clinics, London SW1X 9AE, UK"},{"name":"The Royal Marsden Hospital, London SW3 6JJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(02)84415-4","article-title":"New remedy for tetanus and other convulsive disorders","volume":"34","year":"1840","journal-title":"Lancet"},{"key":"ref_2","unstructured":"(2022, July 28). House of Lords\u2014Science and Technology\u2014Ninth Report. Available online: https:\/\/publications.parliament.uk\/pa\/ld199798\/ldselect\/ldsctech\/151\/15101.htm."},{"key":"ref_3","unstructured":"(2022, July 28). Rescheduling of Cannabis-Based Products for Medicinal Use in Humans (Accessible Version)\u2014GOV.UK, Available online: https:\/\/www.gov.uk\/government\/publications\/circular-0182018-rescheduling-of-cannabis-based-products-for-medicinal-use-in-humans\/rescheduling-of-cannabis-based-products-for-medicinal-use-in-humans-accessible-version."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"K\u00f6stenberger, M., Nahler, G., Jones, T.M., Neuwersch, S., and Likar, R. (2021). The Role of Cannabis, Cannabidiol and Other Cannabinoids in Chronic Pain. The Perspective of Physicians. J. Neuroimmune Pharmacol.","DOI":"10.1007\/s11481-021-10010-x"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/002204260303300204","article-title":"Using Cannabis Therapeutically in the UK: A Qualitative Analysis","volume":"33","author":"Coomber","year":"2016","journal-title":"J. Drug Issues"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/sj.clpt.6100200","article-title":"Vaporization as a Smokeless Cannabis Delivery System: A Pilot Study","volume":"82","author":"Abrams","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s40265-018-0996-1","article-title":"Medical Use of Cannabinoids","volume":"78","year":"2018","journal-title":"Drugs"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jpain.2015.07.009","article-title":"Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-Analysis of Individual Patient Data","volume":"16","author":"Andreae","year":"2015","journal-title":"J. Pain"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jpain.2016.05.010","article-title":"An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease","volume":"17","author":"Wilsey","year":"2016","journal-title":"J. Pain"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jpain.2012.10.009","article-title":"Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain","volume":"14","author":"Wilsey","year":"2013","journal-title":"J. Pain"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/npp.2008.120","article-title":"Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial","volume":"34","author":"Ellis","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"E694","DOI":"10.1503\/cmaj.091414","article-title":"Smoked Cannabis for Chronic Neuropathic Pain: A Randomized Controlled Trial","volume":"182","author":"Ware","year":"2010","journal-title":"CMAJ"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jpain.2015.07.014","article-title":"Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS)","volume":"16","author":"Ware","year":"2015","journal-title":"J. Pain"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1503\/cmaj.110837","article-title":"Smoked Cannabis for Spasticity in Multiple Sclerosis: A Randomized, Placebo-Controlled Trial","volume":"184","author":"Wolfson","year":"2012","journal-title":"CMAJ"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/ejp.1605","article-title":"The Pharmacokinetics, Efficacy, and Safety of a Novel Selective-Dose Cannabis Inhaler in Patients with Chronic Pain: A Randomized, Double-Blinded, Placebo-Controlled Trial","volume":"24","author":"Almog","year":"2020","journal-title":"Eur. J. Pain"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1089\/jwh.2020.8737","article-title":"Use of Cannabis for Self-Management of Chronic Pelvic Pain","volume":"30","author":"Carrubba","year":"2020","journal-title":"J. Women\u2019s Health"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.joim.2020.07.004","article-title":"Alleviative Effects of Cannabis Flower on Migraine and Headache","volume":"18","author":"Stith","year":"2020","journal-title":"J. Integr. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/j.pain.0000000000001464","article-title":"An Experimental Randomized Study on the Analgesic Effects of Pharmaceutical-Grade Cannabis in Chronic Pain Patients with Fibromyalgia","volume":"160","author":"Niesters","year":"2019","journal-title":"Pain"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jad.2018.04.054","article-title":"A Naturalistic Examination of the Perceived Effects of Cannabis on Negative Affect","volume":"235","author":"Cuttler","year":"2018","journal-title":"J. Affect. Disord."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s42238-020-00051-z","article-title":"The Effectiveness of Inhaled Cannabis Flower for the Treatment of Agitation\/Irritability, Anxiety, and Common Stress","volume":"2","author":"Stith","year":"2020","journal-title":"J. Cannabis Res."},{"key":"ref_21","first-page":"251","article-title":"The Effectiveness of Cannabis Flower for Immediate Relief from Symptoms of Depression","volume":"93","author":"Li","year":"2020","journal-title":"Yale J. Biol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/jcph.1961","article-title":"Clinical Outcome Data of First Cohort of Chronic Pain Patients Treated with Cannabis-Based Sublingual Oils in the United Kingdom: Analysis From the UK Medical Cannabis Registry","volume":"61","author":"Kawka","year":"2021","journal-title":"J. Clin. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fpain.2022.891498","article-title":"Characteristics of People Seeking Prescribed Cannabinoids for the Treatment of Chronic Pain: Evidence From Project Twenty 21","volume":"3","author":"Schlag","year":"2022","journal-title":"Front. Pain Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"108586","DOI":"10.1016\/j.neuropharm.2021.108586","article-title":"Current Controversies in Medical Cannabis: Recent Developments in Human Clinical Applications and Potential Therapeutics","volume":"191","author":"Schlag","year":"2021","journal-title":"Neuropharmacology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00213-021-05855-2","article-title":"Developing a Real-World Evidence Base for Prescribed Cannabis in the United Kingdom: Preliminary Findings from Project Twenty21","volume":"239","author":"Sakal","year":"2021","journal-title":"Psychopharmacology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1089\/can.2015.29003.ebr","article-title":"The Cannabis Sativa Versus Cannabis Indica Debate: An Interview with Ethan Russo, MD","volume":"1","author":"Piomelli","year":"2016","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_27","unstructured":"(2018). Deutsches Arzneibuch 2018 (DAB). Allgemeiner Teil. Monographien Cannabisbl\u00fcten-Cannabis Flos, Deutscher Apotheker Verlag."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Lanz, C., Mattsson, J., Soydaner, U., and Brenneisen, R. (2016). Medicinal Cannabis: In Vitro Validation of Vaporizers for the Smoke-Free Inhalation of Cannabis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0147286"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000505027","article-title":"Development of a Vaping Machine for the Sampling of THC and CBD Aerosols Generated by Two Portable Dry Herb Cannabis Vaporisers","volume":"3","author":"Carrara","year":"2020","journal-title":"Med. Cannabis Cannabinoids"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.3109\/08958370902748559","article-title":"Cannabis Smoke Condensate III: The Cannabinoid Content of Vaporised Cannabis Sativa","volume":"21","author":"Pomahacova","year":"2009","journal-title":"Inhal. Toxicol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hec.3564","article-title":"Valuing Health-Related Quality of Life: An EQ-5D-5L Value Set for England","volume":"27","author":"Devlin","year":"2018","journal-title":"Health Econ."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12991-018-0203-5","article-title":"Validity of the PHQ-9 and PHQ-2 to Screen for Depression in Nationwide Primary Care Population in Latvia","volume":"17","author":"Rancans","year":"2018","journal-title":"Ann. Gen. Psychiatry"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: A New Instrument for Psychiatric Practice and Research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00002508-200409000-00005","article-title":"Validity of the Brief Pain Inventory for Use in Documenting the Outcomes of Patients with Noncancer Pain","volume":"20","author":"Keller","year":"2004","journal-title":"Clin. J. Pain"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Jordan, P., Shedden-Mora, M.C., and L\u00f6we, B. (2017). Psychometric Analysis of the Generalized Anxiety Disorder Scale (GAD-7) in Primary Care Using Modern Item Response Theory. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0182162"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1087-0792(03)00044-3","article-title":"How Do Sleep Disturbance and Chronic Pain Inter-Relate? Insights from the Longitudinal and Cognitive-Behavioral Clinical Trials Literature","volume":"8","author":"Smith","year":"2004","journal-title":"Sleep Med. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and Pharmacodynamics of Cannabinoids","volume":"42","author":"Grotenhermen","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1093\/pm\/pny176","article-title":"Restored Self: A Phenomenological Study of Pain Relief by Cannabis","volume":"20","author":"Shvartzman","year":"2019","journal-title":"Pain Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejim.2018.01.004","article-title":"Practical Considerations in Medical Cannabis Administration and Dosing","volume":"49","author":"MacCallum","year":"2018","journal-title":"Eur. J. Intern. Med."},{"key":"ref_40","first-page":"69","article-title":"Health Outcomes among Adults Initiating Medical Cannabis for Chronic Pain: A 3-Month Prospective Study Incorporating Ecological Momentary Assessment (EMA)","volume":"4","author":"Wang","year":"2021","journal-title":"Cannabis (Res. Soc. Marijuana)"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1037\/pha0000435","article-title":"No Pain, All Gain? Interim Analyses from a Longitudinal, Observational Study Examining the Impact of Medical Cannabis Treatment on Chronic Pain and Related Symptoms","volume":"29","author":"Gruber","year":"2021","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"854795","DOI":"10.3389\/fpain.2022.854795","article-title":"Sex-Dependent Prescription Patterns and Clinical Outcomes Associated with the Use of Two Oral Cannabis Formulations in the Multimodal Management of Chronic Pain Patients in Colombia","volume":"3","author":"Madiedo","year":"2022","journal-title":"Front. Pain Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1191\/1352458504ms1082oa","article-title":"Do Cannabis-Based Medicinal Extracts Have General or Specific Effects on Symptoms in Multiple Sclerosis? A Double-Blind, Randomized, Placebo-Controlled Study on 160 Patients","volume":"10","author":"Wade","year":"2004","journal-title":"Mult. Scler."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jhealeco.2017.12.007","article-title":"Do Medical Marijuana Laws Reduce Addictions and Deaths Related to Pain Killers?","volume":"58","author":"Powell","year":"2018","journal-title":"J. Health Econ."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/ADM.0000000000000404","article-title":"Does Medical Cannabis Use Increase or Decrease the Use of Opioid Analgesics and Other Prescription Drugs?","volume":"12","author":"Bachhuber","year":"2018","journal-title":"J. Addict. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/07067437211043393","article-title":"Generalized Anxiety Disorder 7-Item (GAD-7) Scores in Medically Authorized Cannabis Patients-Ontario and Alberta, Canada","volume":"67","author":"Lee","year":"2022","journal-title":"Can. J. Psychiatry."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/npp.2015.336","article-title":"Brain Mapping-Based Model of \u0394 9-Tetrahydrocannabinol Effects on Connectivity in the Pain Matrix","volume":"41","author":"Walter","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"E1285","DOI":"10.1212\/WNL.0000000000006293","article-title":"Cannabis Analgesia in Chronic Neuropathic Pain Is Associated with Altered Brain Connectivity","volume":"91","author":"Weizman","year":"2018","journal-title":"Neurology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1001\/jamapsychiatry.2018.2503","article-title":"Association of Cannabinoid Administration with Experimental Pain in Healthy Adults: A Systematic Review and Meta-Analysis","volume":"75","author":"Moskal","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Raymundi, A.M., Da Silva, T.R., Sohn, J.M.B., Bertoglio, L.J., and Stern, C.A. (2020). Effects of \u2206 9-Tetrahydrocannabinol on Aversive Memories and Anxiety: A Review from Human Studies. BMC Psychiatry, 20.","DOI":"10.1186\/s12888-020-02813-8"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S2215-0366(14)70305-0","article-title":"The Dorsal Medial Prefrontal (Anterior Cingulate) Cortex\u2014Amygdala Aversive Amplification Circuit in Unmedicated Generalised and Social Anxiety Disorders: An Observational Study","volume":"1","author":"Robinson","year":"2014","journal-title":"Lancet Psychiatry"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature00839","article-title":"The Endogenous Cannabinoid System Controls Extinction of Aversive Memories","volume":"418","author":"Marsicano","year":"2002","journal-title":"Nature"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1523\/JNEUROSCI.5603-07.2008","article-title":"Cannabinoid Modulation of Amygdala Reactivity to Social Signals of Threat in Humans","volume":"28","author":"Phan","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000517154","article-title":"Much Ado about Dosing: The Needs and Challenges of Defining a Standardized Cannabis Unit","volume":"4","author":"Jugl","year":"2021","journal-title":"Med. Cannabis Cannabinoids"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/17425247.2019.1653852","article-title":"A Meta-Opinion: Cannabinoids Delivered to Oral Mucosa by a Spray for Systemic Absorption Are Rather Ingested into Gastro-Intestinal Tract: The Influences of Fed \/ Fasting States","volume":"16","author":"Itin","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"531","DOI":"10.7326\/M18-2809","article-title":"Acute Illness Associated with Cannabis Use, by Route of Exposure: An Observational Study","volume":"170","author":"Monte","year":"2019","journal-title":"Ann. Intern. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s12325-018-0805-y","article-title":"Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician","volume":"35","author":"Blonde","year":"2018","journal-title":"Adv. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000514732","article-title":"Evidence in Context: High Risk of Bias in Medical Cannabis and Cannabinoid Clinical Trials Dictates the Need for Cautious Interpretation","volume":"4","author":"Brown","year":"2021","journal-title":"Med. Cannabis Cannabinoids"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/10\/2576\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:53:53Z","timestamp":1760144033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/10\/2576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,14]]},"references-count":58,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["biomedicines10102576"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10102576","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,14]]}}}